Results 81 to 90 of about 225,084 (264)

List of protease inhibitors with transcriptomics and protein expression.

open access: yes, 2022
List of protease inhibitors with transcriptomics and protein expression.
Antonia Vlahou (114470)   +3 more
core   +1 more source

Developmental programmes drive cellular plasticity, disease progression and therapy resistance in lung adenocarcinoma

open access: yesMolecular Oncology, EarlyView.
This study shows that lung adenocarcinomas exploit developmental branching morphogenesis to acquire a therapy resistant basal‐like tumour cell state. This process was found to be regulated by combined TP53 loss‐of‐function and type‐I interferon signalling, identifying a novel axis for biomarker and therapeutic target discovery.
Kamila J Bienkowska   +13 more
wiley   +1 more source

Plasma-Derived miRNAs as Fluid Biomarkers to Differentiate Alzheimer’s and Frontotemporal Dementia

open access: yesCurrent Issues in Molecular Biology
Alzheimer’s disease (AD) and Frontotemporal Dementia (FTD) are complex neurodegenerative disorders, often sharing overlapping symptoms. Non-coding RNAs may be involved in pathological processes in these conditions, hence the study of miRNAs isolated from
Rosalinda Di Gerlando   +9 more
doaj   +1 more source

uap: reproducible and robust HTS data analysis

open access: yesBMC Bioinformatics, 2019
Background A lack of reproducibility has been repeatedly criticized in computational research. High throughput sequencing (HTS) data analysis is a complex multi-step process.
Christoph Kämpf   +7 more
doaj   +1 more source

Flow Enabled Target Capture Halbach‐based magnetic enrichment increases circulating tumor cell capture from blood in metastatic cancer patients

open access: yesMolecular Oncology, EarlyView.
Pair‐wise comparison of the CellSearch and FETCH enrichment technologies for circulating tumor cells (CTCs) from metastatic breast, prostate, and small cell lung cancer patients shows an increased capture of CTCs using FETCH enrichment. The clinical implementation of circulating tumor cells (CTCs) as a predictive tool for therapy efficacy in the ...
Michiel Stevens   +6 more
wiley   +1 more source

Spatial transcriptomics data for 2 patients with kidney fibrosis

open access: yes, 2023
spatial transcriptomics dataset from 2 patients , with kidney ...
Fatima Mechta-Grigoriou (7448858)
core   +1 more source

USP29‐regulated noncanonical stabilization of the hypoxia‐inducible factor‐α in aggressive prostate cancer

open access: yesMolecular Oncology, EarlyView.
We identify USP29 as the only DUB mirroring CA9 expression, a marker of hypoxia and HIF pathway activation associated with PCA aggressiveness. USP29 stabilizes HIF‐1α and HIF‐2α via a noncanonical mechanism that is independent of PHD/pVHL activity yet relies on proteasomal regulation, establishing USP29 as a previously unrecognized regulator of hypoxic
Amelie S Schober   +16 more
wiley   +1 more source

Transcriptomics is essential but not sufficient to unravel complex plant–pathogen interactions

open access: yes
Key message: A group of genes that were upregulated in a resistant cultivar while downregulated in a susceptible cultivar in a transcriptomics analysis of potato challenged by Spongospora subterranea infection, did not show the same expression pattern at
Balotf, Sadegh   +2 more
core   +1 more source

Exploring the frontiers of transcriptomics: Methods, applications, and future perspectives [PDF]

open access: yes
Background: By allowing for the thorough characterization of gene expression, transcriptomics—the study of RNA transcripts generated by the genome—has transformed molecular biology and biomedical research.
Alsadun, ‏Jawaher Sadun   +12 more
core   +1 more source

Reproducibility in Cancer Transcriptomics Research

open access: yes, 2022
Slide deck of my talk on Reproducibility in Cancer Transcriptomics Research during October Omics Codeathon organised by the African Society for Bioinformatics and Computational ...
Ahmad, Umar, Ahmad Umar
core   +1 more source

Home - About - Disclaimer - Privacy